Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers

Bioinformatics

Volumn 32, Issue 1, 2016, Pages 96-105

  Lee, Eunjee ^a   Ito, Koichi ^a   Zhao, Yong ^a   Schadt, Eric E ^a   Irie, Hanna Y ^a   Zhu, Jun ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

BREAST TUMOR; COHORT ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PROGNOSIS; REPRODUCIBILITY; SOFTWARE; SURVIVAL RATE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; MOLECULAR SEQUENCE ANNOTATION; NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SOFTWARE; SURVIVAL RATE;

EID: 84959926512     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv531     Document Type: Article

References (52)

1. Arora, A. and Simpson, D. A. (2008) Individual mRNA expression profiles reveal the effects of specific microRNAs. Genome Biol, 9, R82.
2. Bentink, S. et al. (2012) Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer. PloS One, 7, e30269.
3. Betel, D. et al. (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites, Genome Biol, 11, R90
4. Boyerinas, B. et al. (2010) The role of let-7 in cell differentiation and cancer. Endocrine-related Cancer, 17, F19-36.
5. Brennan, C. W. et al. (2013) The somatic genomic landscape of glioblastoma. Cell, 155, 462-477.
6. Buffa, F. M. et al. (2011) microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Research, 71, 5635-5645.
7. Calin, G. A. et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New Engl J Med, 353, 1793-1801.
8. Cancer Genome Atlas, N. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
9. Cancer Genome Atlas, N. (2012) Comprehensive molecular portraits of human breast tumours. Nature, 490, 61-70.
10. Chen, Y. et al. (2008) Variations in DNA elucidate molecular networks that cause disease. Nature, 452, 429-435.
11. Cheng, C. et al. (2009) mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol, 10, R90.
12. Ciriello, G. et al. (2013) Emerging landscape of oncogenic signatures across human cancers. Nat Genet, 45, 1127-1133.
13. Doench, J. G. and Sharp, P. A. (2004) Specificity of microRNA target selection in translational repression. Genes Dev, 18, 504-511.
14. Dvinge, H. et al. (2013) The shaping and functional consequences of the microRNA landscape in breast cancer. Nature, 497, 378-382.
15. Ebert, M. S. et al. (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods, 4, 721-726.
16. Elefant, N. et al. (2011) A wide repertoire of miRNA binding sites: Prediction and functional implications. Bioinformatics, 27, 3093-3101.
17. Farazi, T. A. et al. (2014) Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. Genome Biol, 15, R9.
18. Gennarino, V. A. et al. (2012) Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res, 22, 1163-1172.
19. Gregory, P. A. et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10, 593-601.
20. Grimson, A. et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell, 27, 91-105.
21. Gruvberger, S. et al. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res, 61, 5979-5984.
22. Guo, L. M. et al. (2009) MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J, 276, 5537-5546.
23. Helwak, A. et al. (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell, 153, 654-665.
24. Hwang-Verslues, W. W. et al. (2011) miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. Oncogene, 30, 2463-2474
25. Hossain, A. et al. (2006) Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol, 26, 8191-8201.
26. Iorio, M. V. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-7070.
27. Jansson, M. D. and Lund, A. H. (2012) MicroRNA and cancer. Mol Oncol, 6, 590-610.
28. Kertesz, M. et al. (2007) The role of site accessibility in microRNA target recognition. Nat Genet, 39, 1278-1284.
29. Krol, J. et al. (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11, 597-610.
30. Lawrie, C. H. (2008) MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy?. J Cell Mol Med, 12, 1432-1444.
31. Madden, S. F. et al. (2010) Detecting microRNA activity from gene expression data. BMC Bioinformatics, 11, 257.
32. Mertens-Talcott, S. U. et al. (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res, 67, 11001-11011.
33. Mouw, J. K. et al. (2014) Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat Med, 20, 360-367.
34. Mullokandov, G. et al. (2012) High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods, 9, 840-846.
35. Pecot, C. V. et al. (2013) Tumour angiogenesis regulation by the miR-200 family. Nat Commun, 4, 2427.
36. Qian, P. et al. (2011) Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res, 71, 6463-6474.
37. Scott, G. K. et al. (2007) Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem, 282, 1479-1486.
38. Setty, M. et al. (2012) Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma. Mol Syst Biolo, 8, 605.
39. Shi, W. et al. (2011) MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res, 71, 2926-2937.
40. Smith, A. L. et al. (2012) The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene, 31, 5162-5171.
41. Song, S. J. et al. (2013) MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell, 154, 311-324.
42. Subramanian, A. et al. (2005) Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A, 102, 15545-15550.
43. Verhaak, R. G. et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98-110.
44. Wu, Z. S. et al. (2010) MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer, 10, 542.
45. Wu, l. et al. (2015) microrna let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein b-cell lymphoma-extra large. Oncol Lett, 9, 213-218.
46. Yu, F. et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131, 1109-1123.
47. Yu, Z. et al. (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol, 182, 509-517.
48. Zhang, Z. et al. (2011) Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells. Genes Cancer, 2, 782-791.
49. Zhang, K. et al. (2013) The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol., 15, 677-687.
50. Zhao, J. J. et al. (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem, 283, 31079-31086.
51. Zhou, X. et al. (2012) MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PloS One, 7, e39011.
52. Zhu, J. et al. (2012) Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation. PLoS Biol, 10, e1001301.